ELISA Kit for Matrix Metalloproteinase 13 (MMP13)
CLG3; Collagenase 3
- Product No.SEA099Eq
- Organism SpeciesEquus caballus; Equine (Horse) Same name, Different species.
- Sample TypeSerum, plasma, tissue homogenates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length3h
- Detection Range0.78-50ng/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 0.29ng/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
For more details, please contact local distributors! US$ 774
For more details, please contact local distributors! US$ 3483
For more details, please contact local distributors! US$ 6579
For more details, please contact local distributors! US$ 54180
For more details, please contact local distributors!
This assay has high sensitivity and excellent specificity for detection of Matrix Metalloproteinase 13 (MMP13).
No significant cross-reactivity or interference between Matrix Metalloproteinase 13 (MMP13) and analogues was observed.
Matrices listed below were spiked with certain level of recombinant Matrix Metalloproteinase 13 (MMP13) and the recovery rates were calculated by comparing the measured value to the expected amount of Matrix Metalloproteinase 13 (MMP13) in samples.
|Matrix||Recovery range (%)||Average(%)|
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Matrix Metalloproteinase 13 (MMP13) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Matrix Metalloproteinase 13 (MMP13) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Matrix Metalloproteinase 13 (MMP13) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
|Pre-coated, ready to use 96-well strip plate||1||Plate sealer for 96 wells||4|
|Detection Reagent A||1×120µL||Assay Diluent A||1×12mL|
|Detection Reagent B||1×120µL||Assay Diluent B||1×12mL|
|TMB Substrate||1×9mL||Stop Solution||1×6mL|
|Wash Buffer (30 × concentrate)||1×20mL||Instruction manual||1|
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.
|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease||Hyaluronan reduces inflammation in experimental arthritis by modulating TLR-2 and TLR-4 cartilage expression ScienceDirect: S0925443911001323|
|Journal of Physiology and Biochemistry||Protective effects of curcumin, α-lipoic acid, and N-acetylcysteine against carbon tetrachloride-induced liver fibrosis in rats SpringerLink: h875w73171w2147w|
|FEBS Journal||Adenosine A2a Receptor Activation and Hyaluronan Fragment Inhibition Reduce Inflammation in Mouse Articular Chondrocytes Stimulated with Il-1beta Wiley: source|
|Arthritis & Rheumatism||Interruption of glycosphingolipid synthesis enhances osteoarthritis development in mice Wiley: source|
|Gene||Hyaluronan in part mediates IL-1beta-induced inflammation in mouse chondrocytes by up-regulating CD44 receptors ScienceDirect: S0378111911007347|
|PLoS ONE||A Combinatorial Relative Mass Value Evaluation of Endogenous Bioactive Proteins in Three-Dimensional Cultured Nucleus Pulposus Cells of Herniated Intervertebral Discs: Identification of Potential Target Proteins for Gene Therapeutic Approaches Plosone: Source|
|Arthritis Rheumatol||Identification of Alpha 2 Macroglobulin (A2M) as a master inhibitor of cartilage degrading factors that attenuates post-traumatic osteoarthritis progression. Pubmed: 24578232|
|Arthritis & Rheumatology||Identification of Alpha 2 Macroglobulin (A2M) as a master inhibitor of cartilage degrading factors that attenuates post-traumatic osteoarthritis progression Onlinelibrary: art.38576|
|Thromb Haemost.||Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke Pubmed:24671655|
|Arthritis & Rheumatol||Identification of α2-Macroglobulin as a Master Inhibitor of Cartilage-Degrading Factors That Attenuates the Progression of Posttraumatic Osteoarthritis Pubmed:24578232|
|Inflammation.?||Systemic and Flap Inflammatory Response Associates with Thrombosis in Flap Venous Crisis Pubmed:25448261|
|Cellular Physiology and Biochemistry||Inverse Regulation of Early and Late Chondrogenic Differentiation by Oxygen Tension Provides Cues for Stem Cell-Based Cartilage Tissue Engineering Pubmed:25632940|
|Osteoarthritis and Cartilage||Depletion of gangliosides enhances cartilage degradation in mice Sciencedirect:S1063458413010364|
|Biol Res||The role of MCP-1-CCR2 ligand-receptor axis in chondrocyte degradation and disease progress in knee osteoarthritis PubMed: 26578310|
|PLoS One||Interleukin-1 Receptor Antagonist Has a Novel Function in the Regulation of Matrix Metalloproteinase-13 Expression PubMed: 26474296|
|Cell Mol Immunol||Toxoplasma gondii GRA15II effector-induced M1 cells ameliorate liver fibrosis in mice infected with Schistosomiasis japonica Pubmed:27157496|
|Scientific Reports||Chondrogenic Potential of Peripheral Blood Derived Mesenchymal Stem Cells Seeded on Demineralized Cancellous Bone Scaffolds pubmed:27821864|
|International Journal of Contemporary Medical Research||Matrix Metalloproteinase-13 (MMP-13): A Novel Tumor Marker for Diagnosis of Breast Carcinoma uploads:7|
|Scientific Reports||Olive and grape seed extract prevents post-traumatic osteoarthritis damages and exhibits in vitro anti IL-1β activities before and after oral consumption. pubmed:27640363|
|Photodermatol Photoimmunol Photomed.||Protective effects of Aloe sterols against UVB‐induced photoaging in hairless mice pubmed:27995657|
|Molecular Medicine Reports||Icariin inhibits MMP‑1, MMP‑3 and MMP‑13 expression through MAPK pathways in IL‑1β‑stimulated SW1353 chondrosarcoma cells pubmed:28447732|
|bmc musculoskeletal disorders||Strontium ranelate causes osteophytes overgrowth in a model of early phase osteoarthritis. pubmed:28187731|
|Journal of Cellular Physiology||Increased Chondrogenic Potential of Mesenchymal Cells From Adipose Tissue Versus Bone Marrow‐Derived Cells in Osteoarthritic In Vitro Models pubmed:27739057|
|BMC Musculoskeletal Disorders||Establishment of rat ankle post-traumatic osteoarthritis model induced by malleolus fracture pubmed:29149841|
|Journal of Applied Animal Research||Hypoxia enhances secretion of matrix metalloproteinases in bovine dermal fibroblasts:an in vitro approach to bovine digital dermatitis 10.108:09712119.2017.1335208|
|Alexandria Journal of Medicine||L-Carnitine ameliorates knee lesions in mono-iodoacetate induced osteoarthritis in rats 10.1016:j.ajme.2016.03.002|
|National Journal of Integrated Research in Medicine||Matrix Metalloproteinase-13 Can Be Used As an Independent Diagnostic and Prognostic Marker for Breast Carcinoma. AN=123116960|
|Catalog No.||Related products for research use of Equus caballus; Equine (Horse) Organism species||Applications (RESEARCH USE ONLY!)|
|RPA099Eq01||Recombinant Matrix Metalloproteinase 13 (MMP13)||Positive Control; Immunogen; SDS-PAGE; WB.|
|PAA099Eq01||Polyclonal Antibody to Matrix Metalloproteinase 13 (MMP13)||WB; IHC; ICC; IP.|
|MAA099Eq21||Monoclonal Antibody to Matrix Metalloproteinase 13 (MMP13)||WB; IHC; ICC; IP.|
|SEA099Eq||ELISA Kit for Matrix Metalloproteinase 13 (MMP13)||Enzyme-linked immunosorbent assay for Antigen Detection.|
|SCA099Eq||CLIA Kit for Matrix Metalloproteinase 13 (MMP13)||Chemiluminescent immunoassay for Antigen Detection.|